Multicenter Prospective Evaluation of Diagnostic Potential of Flow Cytometric Aberrancies in Myelodysplastic Syndromes
Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Arjan A. van de Loosdrecht(Dutch Cancer Society), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Sung‐Chao Chu(Buddhist Tzu Chi General Hospital), Theresia M. Westers(Vrije Universiteit Amsterdam), Dolores Subirá(Hospital Universitario de Guadalajara), Ulrika Johansson(University Hospitals Bristol NHS Foundation Trust), Kate Burbury(The University of Melbourne), Anna Porwit(Lund University), Kíyoyuki Ogata, Alan Dunlop(King's College Hospital), Marie C. Béné(Centre Hospitalier Universitaire de Nantes), Lisa Eidenschink Brodersen, Frauke Bellos(Munich Leukemia Laboratory (Germany)), Leonie Saft(Karolinska University Hospital), Sergio Matarraz(Universidad de Salamanca), Matteo Giovanni Della Porta(Humanitas University), Frank Preijers, Peter Bettelheim, Matthew Cullen(Leeds Teaching Hospitals NHS Trust), Elisabeth H. Weiss(Biogen (United States)), Katherina Psarra(Evangelismos Hospital)
Cited by 0
Related Papers
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k